Healthcare provider profile · identity verified

Seth Roiko, APRN FNP-C

Nurse Practitioner · PARK RAPIDS, MN · NPI 1457735128

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	151
Lisinopril	Lisinopril	364	117
Rosuvastatin Calcium	Rosuvastatin Calcium	330	98
Amlodipine Besylate	Amlodipine Besylate	306	108
Omeprazole	Omeprazole	266	89
Levothyroxine Sodium	Levothyroxine Sodium	250	78
Metoprolol Succinate	Metoprolol Succinate	247	87
Losartan Potassium	Losartan Potassium	225	76
Metformin Hcl Er	Metformin Hcl	197	61
Hydrochlorothiazide	Hydrochlorothiazide	191	67
Tamsulosin Hcl	Tamsulosin Hcl	179	61
Gabapentin	Gabapentin	176	61
Furosemide	Furosemide	173	57
Simvastatin	Simvastatin	172	52
Metformin Hcl	Metformin Hcl	153	48
Warfarin Sodium	Warfarin Sodium	132	46
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	130	27
Prednisone	Prednisone	109	74
Allopurinol	Allopurinol	108	37
Pantoprazole Sodium	Pantoprazole Sodium	108	40
Albuterol Sulfate Hfa	Albuterol Sulfate	106	43
Metoprolol Tartrate	Metoprolol Tartrate	101	36
Potassium Chloride	Potassium Chloride	92	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	78	25
Duloxetine Hcl	Duloxetine Hcl	74	26
Clopidogrel	Clopidogrel Bisulfate	72	22
Ozempic	Semaglutide	72	21
Famotidine	Famotidine	64	21
Trulicity	Dulaglutide	64	17
Eliquis	Apixaban	61	19
Carvedilol	Carvedilol	57	17
Trazodone Hcl	Trazodone Hcl	56	28
Celecoxib	Celecoxib	55	18
Atenolol	Atenolol	54	17
Glipizide Er	Glipizide	54	14
Escitalopram Oxalate	Escitalopram Oxalate	53	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	16
Pravastatin Sodium	Pravastatin Sodium	53	17
Sertraline Hcl	Sertraline Hcl	53	20
Quetiapine Fumarate	Quetiapine Fumarate	51	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	49	20
Citalopram Hbr	Citalopram Hydrobromide	47	18
Ventolin Hfa	Albuterol Sulfate	47	22
Xarelto	Rivaroxaban	47	13
Zolpidem Tartrate	Zolpidem Tartrate	47	suppressed
Montelukast Sodium	Montelukast Sodium	45	16
Azithromycin	Azithromycin	44	42
Triamcinolone Acetonide	Triamcinolone Acetonide	44	29
Fluticasone Propionate	Fluticasone Propionate	42	16
Glipizide	Glipizide	42	14
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	34
Tramadol Hcl	Tramadol Hcl	42	17
Finasteride	Finasteride	39	17
Buspirone Hcl	Buspirone Hcl	38	15
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	37	34
Alprazolam	Alprazolam	36	suppressed
Novolog Flexpen	Insulin Aspart	35	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	35	suppressed
Mirtazapine	Mirtazapine	34	suppressed
Spironolactone	Spironolactone	34	11
Pregabalin	Pregabalin	33	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	15
Jardiance	Empagliflozin	32	suppressed
Levetiracetam	Levetiracetam	32	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	30	25
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Diclofenac Sodium	Diclofenac Sodium	27	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	27	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Tizanidine Hcl	Tizanidine Hcl	27	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Naproxen	Naproxen	26	suppressed
Glimepiride	Glimepiride	25	suppressed
Lorazepam	Lorazepam	25	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	25	suppressed
Ezetimibe	Ezetimibe	24	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	24	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Doxepin Hcl	Doxepin Hcl	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Cefdinir	Cefdinir	22	18
Nitroglycerin	Nitroglycerin	21	16
Bupropion Xl	Bupropion Hcl	19	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	19	suppressed
Nystatin	Nystatin	19	suppressed
Synthroid	Levothyroxine Sodium	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	12
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Anastrozole	Anastrozole	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	16	suppressed
Creon	Lipase/Protease/Amylase	16	suppressed
Gemfibrozil	Gemfibrozil	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Amoxicillin	Amoxicillin	14	12
Clonidine Hcl	Clonidine Hcl	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Fentanyl	Fentanyl	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Methylprednisolone	Methylprednisolone	14	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	14	suppressed
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	14	suppressed
Telmisartan	Telmisartan	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	13	suppressed
Bumetanide	Bumetanide	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Dulera	Mometasone/Formoterol	13	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Temazepam	Temazepam	13	suppressed
Zolmitriptan	Zolmitriptan	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Bydureon Bcise	Exenatide Microspheres	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Digoxin	Digoxin	12	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Oxycodone Hcl	Oxycodone Hcl	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	12	suppressed
Tresiba Flextouch U-200	Insulin Degludec	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mesalamine	Mesalamine	11	suppressed
Verapamil Er	Verapamil Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error